Sputnik V COVID-19 Vaccine Candidate Appears Safe and Effective - The Lancet
Denis Logunov and colleagues1 report their interim results from a phase 3 trial of the Sputnik V COVID-19 vaccine in The Lancet. The trial results show a consistent strong protective effect across all participant age groups.
